In a major blow to the 340B provider community, U.S. Rep. David McKinley, the leading voice for the 340B program in the House Republican caucus, was defeated Tuesday in the West Virginia Republican primary. McKinley will remain in office until the end of the year, but his influence will likely wane.
McKinley’s loss to fellow incumbent Rep. Alex Mooney is a major setback for backers of bipartisan bills to expand rural hospitals’ access to 340B drug discounts on orphan drugs and to protect all entities from discrimination by pharmacy benefit managers (PBMs). McKinley also helps lead bipartisan congressional opposition to drug manufacturers’ conditions on 340B pricing when entities contract with outside pharmacies.
In a major blow to the 340B provider community, U.S. Rep. David McKinley, the leading voice for the 340B program in the House Republican caucus, was defeated Tuesday in the West Virginia Republican primary. McKinley will remain in office until the end of the year, but his influence will likely wane.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
